Trial intelligence / Profile preview

Gabapentin for dysgeusia after ear surgery

IRCT20200525047566N1Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Aug 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of gabapentin in dysgeusia, sponsored by Shahid Beheshti University of Medical Sciences. Started Aug 2020; status: completed.

02

Drugs

gabapentin
03

Conditions

dysgeusia

Beyond the preview

Go deeper on IRCT20200525047566N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200525047566N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call